Lonza (Switzerland) and Epithelix (Switzerland) are the Leading Players in the In Vitro Lung Model Market
The global lung in vitro models market is projected to reach USD 427.4 Million by 2023 from USD 190.5 Million in 2018 at a CAGR [read full press release…]